Regulatory leadership Biologics Consulting is a long-standing FDA regulatory and product development partner with expertise across biologics, devices, pharmaceuticals, and biosimilars, signaling a strong foundation for selling end-to-end regulatory and submission services to growth-stage biotech and established pharma players.

Growth through new leadership Recent appointment of a new CEO suggests strategic direction shifts and potential expanded sales outreach, presenting an opportunity to engage at the executive level to discuss expanded service offerings and growth initiatives.

Global client base With over 4,500 clients across 58 countries, Biologics Consulting demonstrates broad market reach and credibility, indicating opportunities to upsell to existing clients or cross-sell across their diverse portfolio of life sciences customers.

Full-service offerings Capabilities span regulatory consulting, clinical planning, quality support, medical writing, and US agent services, enabling multi-service proposals to clients pursuing end-to-end product development and commercialization.

Financial potential Reported revenue range of 250 to 500 million positions Biologics Consulting as a mid-to-large firm with significant procurement budgets, suggesting opportunities for long-term multi-year engagements and strategic partnerships.